This page is a permanent link to the reply below and its nested replies. See all post replies »
ElwoodBlues · M
Current flu vaccines are manufactured by growing viruses in eggs, a process that usually takes 6-8 months. mRNA vaccines can be manufactured in 1-2 months.
That means mRNA vaccines can offer a faster more flexible response to an emerging strain of flu, admittedly at higher cost. mRNA vaccines would thus be the preferred choice for the elderly. Meanwhile economies of scale will bring down the mRNA cost.
Could it be that traditional makers of egg-based vaccines don't want faster more modern competition??
That means mRNA vaccines can offer a faster more flexible response to an emerging strain of flu, admittedly at higher cost. mRNA vaccines would thus be the preferred choice for the elderly. Meanwhile economies of scale will bring down the mRNA cost.
Could it be that traditional makers of egg-based vaccines don't want faster more modern competition??



